193 related articles for article (PubMed ID: 26930717)
1. Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition.
Banno A; Garcia DA; van Baarsel ED; Metz PJ; Fisch K; Widjaja CE; Kim SH; Lopez J; Chang AN; Geurink PP; Florea BI; Overkleeft HS; Ovaa H; Bui JD; Yang J; Chang JT
Oncotarget; 2016 Apr; 7(16):21527-41. PubMed ID: 26930717
[TBL] [Abstract][Full Text] [Related]
2. Role of p38γ MAPK in regulation of EMT and cancer stem cells.
Xu M; Wang S; Wang Y; Wu H; Frank JA; Zhang Z; Luo J
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3605-3617. PubMed ID: 30251680
[TBL] [Abstract][Full Text] [Related]
3. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
4. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation.
Fantozzi A; Gruber DC; Pisarsky L; Heck C; Kunita A; Yilmaz M; Meyer-Schaller N; Cornille K; Hopfer U; Bentires-Alj M; Christofori G
Cancer Res; 2014 Mar; 74(5):1566-75. PubMed ID: 24413534
[TBL] [Abstract][Full Text] [Related]
5. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
6. The epithelial-mesenchymal transition in cancer: a potential critical topic for translational proteomic research.
Bottoni P; Isgrò MA; Scatena R
Expert Rev Proteomics; 2016; 13(1):115-33. PubMed ID: 26567562
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.
Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ
J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011
[TBL] [Abstract][Full Text] [Related]
8. In vivo imaging, tracking, and targeting of cancer stem cells.
Vlashi E; Kim K; Lagadec C; Donna LD; McDonald JT; Eghbali M; Sayre JW; Stefani E; McBride W; Pajonk F
J Natl Cancer Inst; 2009 Mar; 101(5):350-9. PubMed ID: 19244169
[TBL] [Abstract][Full Text] [Related]
9. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
Liu X; Fan D
Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.
Mallini P; Lennard T; Kirby J; Meeson A
Cancer Treat Rev; 2014 Apr; 40(3):341-8. PubMed ID: 24090504
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.
Zhou M; Hou Y; Yang G; Zhang H; Tu G; Du YE; Wen S; Xu L; Tang X; Tang S; Yang L; Cui X; Liu M
Stem Cells; 2016 Jan; 34(1):55-66. PubMed ID: 26418365
[TBL] [Abstract][Full Text] [Related]
12. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
13. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
Xu Q; Sun Q; Zhang J; Yu J; Chen W; Zhang Z
Carcinogenesis; 2013 Mar; 34(3):539-49. PubMed ID: 23188671
[TBL] [Abstract][Full Text] [Related]
15. The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells.
Lagadec C; Vlashi E; Frohnen P; Alhiyari Y; Chan M; Pajonk F
Stem Cells; 2014 Jan; 32(1):135-44. PubMed ID: 24022895
[TBL] [Abstract][Full Text] [Related]
16. Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity.
Beerling E; Seinstra D; de Wit E; Kester L; van der Velden D; Maynard C; Schäfer R; van Diest P; Voest E; van Oudenaarden A; Vrisekoop N; van Rheenen J
Cell Rep; 2016 Mar; 14(10):2281-8. PubMed ID: 26947068
[TBL] [Abstract][Full Text] [Related]
17. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes.
Liu F; Kong X; Lv L; Gao J
Cancer Lett; 2015 Apr; 359(2):288-98. PubMed ID: 25633840
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer.
Zhang JT; Jiang XH; Xie C; Cheng H; Da Dong J; Wang Y; Fok KL; Zhang XH; Sun TT; Tsang LL; Chen H; Sun XJ; Chung YW; Cai ZM; Jiang WG; Chan HC
Biochim Biophys Acta; 2013 Dec; 1833(12):2961-2969. PubMed ID: 23916755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
